Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2025-12-24 @ 5:09 PM
NCT ID:
NCT03033550
Eligibility Criteria:
Inclusion Criteria:
* AFG ages 30 years and older who receive primary care at the study sites.
* AFG consent to have cervical cancer screening status checked in Electronic Medical Record.
* AFG has a daughter between the ages of 11 to 17 who receive primary care at either
* Family Medicine or Pediatric and Adolescent primary care clinic at Boston Medical Center.
* AFG consent to have daughter's HPV vaccination status checked in Electronic Medical Record.
* AFG's daughter has neither initiated the HPV vaccine nor completed the three vaccine series
* AFG and daughter have the ability to read and write in English.
* AFG and daughter each have a cell phone with text messages capabilities.
Exclusion Criteria:
* The investigators will exclude based on the following criteria:
* AFG being seen for a sick visit.
* AFG has an adolescent daughter who is pregnant or is a mother.
* AFG has a daughter who has completed the three dose HPV vaccine series.
* AFG, in the opinion of the clinical staff, is cognitively impaired and unable to give informed consent and may not participate.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
9 Years
Maximum Age:
17 Years
Study:
NCT03033550
Study Brief:
Protocol Section:
NCT03033550